Elevance Health, Inc.
DE ˙ XTRA
333,90 € ↓ -10,80 (-3,13%)
2026-06-03
DEL PRIS
SecurityDE:A58 / Elevance Health, Inc.
InstitutionFulton Bank, N.a.
Latest Disclosed Ownership860 shares
Latest Disclosed Value $ 251,764
Fulton Bank, N.a. reports 0.58% increase in ownership of A58 / Elevance Health, Inc.

On April 24, 2026 - Fulton Bank, N.a. filed a 13F-HR form disclosing ownership of 860 shares of Elevance Health, Inc. (DE:A58) valued at $213,538 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 855 shares of Elevance Health, Inc.. This represents a change in shares of 0.58% during the quarter. The current value of the position is $287,154 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 860 5 0.58 252 -16.05 0.0049
2026-01-08 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 855 48 5.95 300 15.00 0.0104
2025-10-21 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 807 -909 -52.97 261 -61.02 0.0091
2025-07-10 2025-06-30 13F ELEVANCE HEALTH COM 036752103 1,716 176 11.43 667 -0.30 0.0247
2025-04-09 2025-03-31 13F ELEVANCE HEALTH COM 036752103 1,540 460 42.59 670 68.09 0.0270
2025-01-08 2024-12-31 13F ELEVANCE HEALTH COM 036752103 1,080 -49 -4.34 398 -32.20 0.0154
2024-10-07 2024-09-30 13F ELEVANCE HEALTH COM 036752103 1,129 -1 -0.09 587 -4.08 0.0224
2024-07-09 2024-06-30 13F ELEVANCE HEALTH COM 036752103 1,130 31 2.82 612 7.56 0.0248
2024-04-10 2024-03-31 13F ELEVANCE HEALTH COM 036752103 1,099 -50 -4.35 570 5.18 0.0234
2024-01-24 2023-12-31 13F/A-1 ELEVANCE HEALTH COM 036752103 1,149 -119 -9.38 542 -1.99 0.0244
2024-01-04 2023-12-31 13F ELEVANCE HEALTH COM 036752103 1,149 -119 542 0.0132
2023-10-04 2023-09-30 13F ELEVANCE HEALTH COM 036752103 1,268 19 1.52 552 -0.36 0.0275
2023-07-06 2023-06-30 13F ELEVANCE HEALTH COM 036752103 1,249 -113 -8.30 555 -11.50 0.0272
2023-04-06 2023-03-31 13F ELEVANCE HEALTH COM 036752103 1,362 179 15.13 626 3.13 0.0329
2023-01-05 2022-12-31 13F ELEVANCE HEALTH COM 036752103 1,183 59 5.25 1 -100.00 0.0342
2022-10-04 2022-09-30 13F ELEVANCE HEALTH COM 036752103 1,124 109 10.74 510 4.08 0.0304
2022-07-07 2022-06-30 13F ELEVANCE HEALTH COM 036752103 1,015 14 1.40 490 -0.20 0.0273
2022-04-05 2022-03-31 13F ANTHEM COM 036752103 1,001 -42 -4.03 491 1.45 0.0230
2022-01-05 2021-12-31 13F ANTHEM COM 036752103 1,043 0 0.00 484 24.42 0.0213
2021-10-05 2021-09-30 13F ANTHEM COM 036752103 1,043 -1,685 -61.77 389 -62.63 0.0181
2021-07-06 2021-06-30 13F ANTHEM COM 036752103 2,728 -133 -4.65 1,041 1.36 0.0485
2021-04-05 2021-03-31 13F ANTHEM COM 036752103 2,861 -204 -6.66 1,027 4.37 0.0518
2021-01-07 2020-12-31 13F ANTHEM COM 036752103 3,065 -107 -3.37 984 15.49 0.0530
2020-10-06 2020-09-30 13F ANTHEM COM 036752103 3,172 -339 -9.66 852 -7.69 0.0524
2020-07-06 2020-06-30 13F ANTHEM COM 036752103 3,511 -4,996 -58.73 923 -52.20 0.0609
2020-04-03 2020-03-31 13F ANTHEM COM 036752103 8,507 256 3.10 1,931 -22.51 0.1541
2020-01-24 2019-12-31 13F ANTHEM COM 036752103 8,251 -268 -3.15 2,492 21.80 0.1548
2019-10-03 2019-09-30 13F ANTHEM COM 036752103 8,519 182 2.18 2,046 -13.05 0.1386
2019-07-03 2019-06-30 13F ANTHEM COM 036752103 8,337 710 9.31 2,353 7.49 0.1589
2019-04-03 2019-03-31 13F ANTHEM COM 036752103 7,627 -599 -7.28 2,189 1.34 0.1532
2019-01-03 2018-12-31 13F ANTHEM COM 036752103 8,226 317 4.01 2,160 -0.32 0.1720
2018-10-03 2018-09-30 13F ANTHEM COM 036752103 7,909 2,131 36.88 2,167 57.60 0.1424
2018-07-10 2018-06-30 13F ANTHEM COM 036752103 5,778 -169 -2.84 1,375 5.20 0.0953
2018-05-02 2018-03-31 13F ANTHEM COM 036752103 5,947 -372 -5.89 1,307 -8.02 0.0915
2018-01-04 2017-12-31 13F ANTHEM COM 036752103 6,319 280 4.64 1,421 23.89 0.1004
2017-10-04 2017-09-30 13F ANTHEM COM 036752103 6,039 2,991 98.13 1,147 99.83 0.0855
2017-07-11 2017-06-30 13F ANTHEM COM 036752103 3,048 511 20.14 574 36.67 0.0446
2017-04-06 2017-03-31 13F ANTHEM COM 036752103 2,537 776 44.07 420 66.01 0.0345
2017-01-05 2016-12-31 13F ANTHEM COM 036752103 1,761 1,761 253 0.0224
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.